Rexhepaj Rexhep, Artunc Ferruh, Grahammer Florian, Nasir Omaima, Sandu Ciprian, Friedrich Björn, Kuhl Dietmar, Lang Florian
Department of Physiology, University of Tübingen, Gmelinstr. 5, 72076 Tübingen, Germany.
Pflugers Arch. 2006 Oct;453(1):97-105. doi: 10.1007/s00424-006-0111-4. Epub 2006 Aug 8.
The serum and glucocorticoid-inducible kinase SGK1 is known to be upregulated by mineralocorticoids and to enhance ENaC activity in several expression systems. Moreover, the amiloride-sensitive transepithelial potential difference in the collecting duct is lower in gene-targeted mice lacking SGK1 (sgk1 (-/-)) than in their wild-type littermates (sgk1 (+/+)). Accordingly, the ability of sgk1 (-/-) mice to decrease urinary sodium output during salt depletion is impaired. These observations highlight the importance of SGK1 in the stimulation of renal ENaC activity. In colonic epithelium, ENaC activity and, thus, transepithelial potential difference (V (te)) are similarly upregulated by mineralocorticoids. The present study thus explored V (te) and the apparent amiloride-sensitive equivalent short circuit current (I (amil)) in the colon from sgk1 (-/-) and sgk1 (+/+) mice before and after treatment with low salt diet, the glucocorticoid dexamethasone [DEXA, 10 mug/g body weight (BW)], or the mineralocorticoid deoxycorticosterone acetate (DOCA, 1.5 mg/day). Surprisingly, V (te) and I (amil) were both significantly (p<0.05) higher in sgk1 (-/-) than in sgk1 (+/+) untreated mice. A 7-day exposure to low salt diet increased V (te) and I (amil) in both genotypes, but did not abrogate the differences of V (te) and I (amil) between sgk1 (-/-) and sgk1 (+/+) mice. Plasma aldosterone levels were significantly higher in sgk1 (-/-) than in sgk1 (+/+) mice both under control conditions and under low salt diet, which may explain the enhanced V (te) in sgk1 (-/-) mice. Treatment with DEXA or DOCA both significantly increased V (te) and I (amil) in sgk1 (+/+) mice and tended to increase V (te) and I (amil) in sgk1 (-/-) mice. Under treatment with DEXA or DOCA, V (te) and I (amil) were similar in sgk1 (-/-) and sgk1 (+/+) mice. Fecal Na(+) excretion was similar in sgk1 (+/+) mice and in sgk1 (-/-) mice and was similarly decreased by low Na(+) diet in both genotypes. In conclusion, transepithelial potential and amiloride-sensitive short circuit current are enhanced in the colonic epithelium of SGK1-deficient mice. Thus, lack of SGK1 does not disrupt colonic ENaC activity and its regulation by salt depletion.
血清和糖皮质激素诱导激酶SGK1已知可被盐皮质激素上调,并在多种表达系统中增强上皮钠通道(ENaC)的活性。此外,在缺乏SGK1(sgk1(-/-))的基因靶向小鼠中,集合管中对阿米洛利敏感的跨上皮电位差低于其野生型同窝小鼠(sgk1(+/+))。因此,sgk1(-/-)小鼠在盐缺乏时减少尿钠排出的能力受损。这些观察结果突出了SGK1在刺激肾脏ENaC活性中的重要性。在结肠上皮中,ENaC活性以及由此产生的跨上皮电位差(V(te))同样可被盐皮质激素上调。因此,本研究探讨了sgk1(-/-)和sgk1(+/+)小鼠在低盐饮食、糖皮质激素地塞米松[DEXA,10μg/g体重(BW)]或盐皮质激素醋酸脱氧皮质酮(DOCA,1.5mg/天)处理前后结肠中的V(te)和表观阿米洛利敏感等效短路电流(I(amil))。令人惊讶的是,在未处理的sgk1(-/-)小鼠中,V(te)和I(amil)均显著(p<0.05)高于sgk1(+/+)小鼠。7天的低盐饮食暴露使两种基因型的V(te)和I(amil)均增加,但并未消除sgk1(-/-)和sgk1(+/+)小鼠之间V(te)和I(amil)的差异。在对照条件和低盐饮食下,sgk1(-/-)小鼠的血浆醛固酮水平均显著高于sgk1(+/+)小鼠,这可能解释了sgk1(-/-)小鼠中V(te)增强的原因。DEXA或DOCA处理均显著增加了sgk1(+/+)小鼠的V(te)和I(amil),并倾向于增加sgk1(-/-)小鼠的V(te)和I(amil)。在DEXA或DOCA处理下,sgk1(-/-)和sgk1(+/+)小鼠的V(te)和I(amil)相似。sgk1(+/+)小鼠和sgk1(-/-)小鼠的粪便钠排泄相似,并且两种基因型在低钠饮食时粪便钠排泄均同样减少。总之,SGK1缺陷小鼠结肠上皮中的跨上皮电位和阿米洛利敏感短路电流增强。因此,缺乏SGK1不会破坏结肠ENaC活性及其通过盐缺乏的调节。